What dalteparin (generic) dose should be given for deep‑vein thrombosis prophylaxis in a 50‑kg adult with normal renal function?

Dalteparin Dosing for DVT Prophylaxis in 50 kg Adult

For DVT prophylaxis in a 50 kg adult with normal renal function, administer dalteparin 5,000 units subcutaneously once daily. 1

Standard Prophylactic Dosing

The recommended dose is not weight-adjusted for prophylaxis in this clinical scenario:

• Hospitalized medical patients: 5,000 units subcutaneously once daily 1
• Surgical patients: Either 2,500 units 2-4 hours preoperatively followed by 5,000 units once daily thereafter, OR 5,000 units 2-4 hours preoperatively or 10-12 hours preoperatively followed by 5,000 units once daily thereafter 1
• Outpatients (cancer patients): 5,000 units subcutaneously once daily 1

Duration of Prophylaxis

• Medical patients: Continue for the length of hospital stay or until fully ambulatory 1
• Surgical patients: Continue for at least 7-10 days; extended prophylaxis for up to 4 weeks should be considered for high-risk patients 1

Special Considerations for Low Body Weight

While limited evidence exists for patients weighing less than 50 kg, the standard fixed prophylactic dose of 5,000 units once daily remains appropriate 1:

• No dose adjustment is recommended for prophylaxis in patients weighing less than 50 kg with normal renal function 1
• Studies in critically ill patients with severe renal insufficiency showed no bioaccumulation with prophylactic dalteparin 5,000 units daily, with peak anti-Xa levels between 0.29-0.34 IU/mL 1, 2
• The fixed prophylactic dosing regimen has been validated across diverse patient populations without weight-based adjustments 1

Important Caveats

Renal function monitoring: Although this patient has normal renal function, be aware that dalteparin requires caution in severe renal insufficiency (CrCl <30 mL/min), where monitoring of peak anti-Xa levels may be warranted for treatment doses 1

Bleeding risk assessment: The standard prophylactic dose of 5,000 units daily has demonstrated acceptable safety profiles without excessive bleeding risk, even in vulnerable populations 2, 3

Not for treatment: This prophylactic dose (5,000 units once daily) is distinct from treatment dosing, which would be weight-based at 200 units/kg once daily or 100 units/kg every 12 hours 1